©The Author(s) 2025.
World J Clin Oncol. Nov 24, 2025; 16(11): 111983
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.111983
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.111983
Table 2 Catalogue of Somatic Mutations in Cancer mutational signatures predominant in each genomic cluster of blast crisis chronic myeloid leukemia
| Cluster | Dominant Catalogue of Somatic Mutations in Cancer signatures |
| Cluster 1 | Signature 3 (breast cancer susceptibility gene-deficiency), signature 5 (aging) |
| Cluster 2 | Signature 1 (5-methylcytosine deamination), signature 2 (apolipoprotein B mRNA editing enzyme catalytic polypeptide) |
| Cluster 3 | Signature 13 (polymerase error), signature 18 (reactive oxygen species-related) |
- Citation: AlGarni A, Alanazi N, AlMukhaylid S, Alqahtani S, Almasoudi H, Samir Taleb Y, Alkhamis N, Shaheen S, Haji Siyal A, Aleem A, Naeem R, Shammas MA, Saglio G, Alroweilly D, Hussain A, Iqbal Z. Omics and artificial intelligence integration for stratifying blast crisis CML using COSMIC signatures and pan-cancer precision drug repurposing. World J Clin Oncol 2025; 16(11): 111983
- URL: https://www.wjgnet.com/2218-4333/full/v16/i11/111983.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i11.111983